The efficacy of tobramycin in the treatment of ulcerative colitis

Alimentary Pharmacology & Therapeutics
D A BurkeR W Lacey

Abstract

This paper reports a double-blind placebo-controlled trial of oral tobramycin in acute ulcerative colitis. Eighty-four patients with an acute relapse of ulcerative colitis were randomized to receive oral tobramycin or placebo for 1 week as an adjunct to steroid therapy. At endpoint, 31 of 42 (74%) in the tobramycin group achieved complete symptomatic remission compared with 18 of 42 (43%) in the placebo group (P = 0.008). The tobramycin group achieved better histological scores (P less than 0.05) at endpoint. These findings show that treatment with oral tobramycin improves the short-term outcome of patients with ulcerative colitis in relapse.

References

Jan 1, 1979·The American Journal of Clinical Nutrition·A B Onderdonk, J G Bartlett
Aug 1, 1976·The Journal of Infectious Diseases·H C Neu
Jul 9, 1988·BMJ : British Medical Journal·D A Burke, A T Axon
Dec 1, 1968·The Journal of Experimental Medicine·R LagercrantzB E Gustafsson
Oct 29, 1955·British Medical Journal·S C TRUELOVE, L J WITTS
Feb 18, 1950·British Medical Journal·G T STEWART

❮ Previous
Next ❯

Citations

Jan 31, 2002·World Journal of Gastroenterology : WJG·David S Rampton, D Phil
Jul 4, 2003·European Journal of Gastroenterology & Hepatology·Klaus FellermannEduard F Stange
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Alan Ronald BremnerRobert Mark Beattie
Apr 9, 2005·Alimentary Pharmacology & Therapeutics·T NomuraN Sato
Apr 28, 2005·Chemotherapy·Paolo GionchettiMassimo Campieri
Oct 13, 2006·Current Opinion in Gastroenterology·P GionchettiM Campieri
Apr 7, 2007·Digestive Diseases and Sciences·Roja RahimiMohammad Abdollahi
Jul 17, 2012·Digestive Diseases·Guillaume P Pineton de ChambrunJean-Frédéric Colombel
Jul 10, 2012·Journal of Pediatric Gastroenterology and Nutrition·Dan TurnerUNKNOWN European Society for Paediatric Gastroenterology, Hepatology, and Nutrition
Sep 9, 2017·The Cochrane Database of Systematic Reviews·Vipul JairathBrian G Feagan
Mar 13, 1998·Journal of the Royal Society of Medicine·D Burke
Oct 6, 2005·Journal of Pediatric Gastroenterology and Nutrition·Subra KugathasanJeffrey Hyams
Jan 5, 2002·Scandinavian Journal of Gastroenterology. Supplement·R K LinskensS G Meuwissen
Jun 29, 2006·Inflammatory Bowel Diseases·Molly Perencevich, Robert Burakoff
Apr 10, 2010·Expert Opinion on Drug Safety·Laura Noddin Rosenberg, Mark A Peppercorn
Jul 25, 2006·Infection and Immunity·Kenneth W SimpsonYnte H Schukken
Jul 14, 2010·Journal of Gastroenterology and Hepatology·Toshiki UeharaMitsuhiko Moriyama
Mar 17, 2011·The American Journal of Gastroenterology·Khurram J KhanPaul Moayyedi
Apr 16, 2011·The American Journal of Gastroenterology·Nicholas J TalleyUNKNOWN American College of Gastroenterology IBD Task Force
Dec 31, 2019·Frontline Gastroenterology·Bincy Abraham, Eamonn M M Quigley
Jan 1, 1992·Scandinavian Journal of Gastroenterology. Supplement·J E Lennard-Jones
Jun 6, 2002·Alimentary Pharmacology & Therapeutics·M DapernoA Pera
Jun 6, 2003·Alimentary Pharmacology & Therapeutics·F RizzelloM Campieri
Aug 29, 2000·Inflammatory Bowel Diseases·B Blomberg, G Järnerot
Mar 3, 2005·Journal of Gastroenterology and Hepatology·Toshifumi Ohkusa, Nobuhiro Sato
Apr 1, 1993·Alimentary Pharmacology & Therapeutics·A J LoboA T Axon
Jun 30, 2005·The American Journal of Gastroenterology·Rodrigo BibiloniR Balfour Sartor
May 26, 2005·Current Treatment Options in Gastroenterology·Chandrashekhar ThukralMark A Peppercorn
May 31, 2006·World Journal of Gastroenterology : WJG·Paolo GionchettiMassimo Campieri
Mar 11, 2010·The American Journal of Gastroenterology·Toshifumi OhkusaUNKNOWN Japan UC Antibiotic Therapy Study Group
Jan 27, 2016·World Journal of Gastroenterology : WJG·Orna NitzanWalid Saliba
Oct 17, 2017·Alimentary Pharmacology & Therapeutics·J McIlroyG L Hold
May 4, 2018·Inflammatory Bowel Diseases·Oren Ledder, Dan Turner
Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·J W Harting
Feb 25, 2006·Digestion·Paolo GionchettiMassimo Campieri
Nov 30, 2000·Current Treatment Options in Gastroenterology·C K Wong, B R Yacyshyn
Oct 16, 2007·Digestive Diseases and Sciences·Sagar GarudCiaran P Kelly
Jun 13, 2000·JPEN. Journal of Parenteral and Enteral Nutrition·R J KennedyK R Gardiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.